Click a link below to view the mailing archive as if it had been sent to you.
| 2023-02-28 12:15 | | Go or no go? Vaccines and neurology up for discussion and more... |
| 2023-02-28 00:15 | | Billy Dunn, FDA’s top neuroscience official to depart agency and more... |
| 2023-02-27 12:15 | | Seagen has a New Suitor as Pfizer Talks Begin and more... |
| 2023-02-27 00:15 | | Fulcrum's clinical hold caps off tough week for sickle cell drug development and more... |
| 2023-02-24 12:15 | | Nektar's bitter pill: Phase 2 fail ends Lilly-partnered lupus program and prompts eczema rethink and more... |
| 2023-02-24 00:15 | | FDA approves Sanofi’s long-lasting hemophilia drug and more... |
| 2023-02-23 12:15 | | Moderna's Cancer Vaccine Wins An FDA Boon, But Shares Drop On Mixed Earnings and more... |
| 2023-02-23 00:15 | | Charles River gets DoJ subpoena on Cambodian supply of lab monkeys and more... |
| 2023-02-22 12:15 | | Medtronic Growth Catalysts to Watch for in 2023 and more... |
| 2023-02-22 00:15 | | Merck’s COVID-19 treatment falls short in prevention study and more... |
| 2023-02-21 12:15 | | Big pharma’s looming threat: a patent cliff of ‘tectonic magnitude’ and more... |
| 2023-02-21 00:15 | | Novartis, Roche avoid $475M antitrust fine in French appeals court and more... |
| 2023-02-17 12:15 | | Pfizer, Valneva remove half of participants from study of Lyme disease shot and more... |
| 2023-02-17 00:15 | | Senate begins quest to demystify PBMs' practices as it mulls legislation and more... |
| 2023-02-16 12:15 | | Seagen mum on Merck buyout rumors as it bats for blockbuster with Adcetris and more... |
| 2023-02-16 00:15 | | Biogen CEO says company 'lost its way,' cuts $125M MS partnership amid declining revenue and more... |
| 2023-02-15 12:15 | | Brent Saunders to Return as Bausch + Lomb CEO and more... |
| 2023-02-14 12:15 | | GSK nixes next-gen COVID-19 antibody collaboration, leaving Vir to fly solo, seek new partners and more... |
| 2023-02-14 00:15 | | US government, Pfizer and others side with Sanofi and Regeneron in Supreme Court patent case and more... |
| 2023-02-13 12:15 | | Amid bankruptcy, Clovis reveals more regulatory troubles for Rubraca and more... |
| 2023-02-13 00:15 | | Bristol Myers details landmark Abecma multiple myeloma data that ASH turned down and more... |
| 2023-02-10 12:15 | | GSK's unusual Jemperli expansion plan wins FDA panel backing—with a twist and more... |
| 2023-02-10 00:15 | | Eli Lilly's employment decisions under fire once again as sales rep lodges age discrimination claim and more... |
| 2023-02-09 12:15 | | What is BioGPT and what does it mean for healthcare? and more... |
| 2023-02-09 00:15 | | Medtronic 'Reveals' New Data on Atrial Fibrillation Detection and more... |
| 2023-02-08 12:15 | | In State of the Union, Biden highlights drug prices, cancer, and affordable care and more... |
| 2023-02-08 00:15 | | Biden to push for universal insulin price cap in State of the Union and more... |
| 2023-02-07 12:15 | | Aldeyra’s sights set on November PDUFA and more... |
| 2023-02-07 00:15 | | Eisai gives first glimpse into Alzheimer’s drug launch and more... |
| 2023-02-06 12:15 | | Vaccines slip, Dupixent climbs for Sanofi as it readies multiple launches in 2023 and more... |
| 2023-02-03 12:15 | | With all eyes on new Alzheimer's med, Eisai lays off 91 staffers on its Fycompa team and more... |
| 2023-02-03 00:15 | | Merck pill linked to new mutations, study says and more... |
| 2023-02-02 12:15 | | Q4 earnings roundup: Merck, Lilly, Takeda and BMS release financials and more... |
| 2023-02-02 00:15 | | Layoffs continue to batter biotech, with Big Pharmas piling on the pain and more... |
| 2023-02-01 12:15 | | GSK, after consumer spinoff, touts momentum for core products Cabenuva and Shingrix and more... |
| 2023-02-01 00:15 | | New York City invests $20M into biotech 'innovation space' at the Brooklyn Navy Yard and more... |
